Renal Effects of SGLT-2 Inhibitors and Other Anti-diabetic Drugs: Clinical Relevance and Potential Risks.

about

Drugs and the Kidneys: Clinical Pharmacology Perspectives.

P2860

Q53122864-1336B7B4-3AC7-4854-9D00-34DEEDE051E6

P2860

Renal Effects of SGLT-2 Inhibitors and Other Anti-diabetic Drugs: Clinical Relevance and Potential Risks.

Item

http://www.wikidata.org/entity/Q39290337

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Renal Effects of SGLT-2 Inhibi ...... Relevance and Potential Risks.

@en

Renal Effects of SGLT-2 Inhibi ...... Relevance and Potential Risks.

@nl

type

Item

label

Renal Effects of SGLT-2 Inhibi ...... Relevance and Potential Risks.

@en

Renal Effects of SGLT-2 Inhibi ...... Relevance and Potential Risks.

@nl

prefLabel

Renal Effects of SGLT-2 Inhibi ...... Relevance and Potential Risks.

@en

Renal Effects of SGLT-2 Inhibi ...... Relevance and Potential Risks.

@nl

P1476

Renal Effects of SGLT-2 Inhibi ...... Relevance and Potential Risks

@en

P2093

E K Daphnis

http://www.w3.org/2001/XMLSchema#string

E Lioudaki

http://www.w3.org/2001/XMLSchema#string

E S Androulakis

http://www.w3.org/2001/XMLSchema#string

E S Ganotakis

http://www.w3.org/2001/XMLSchema#string

M Whyte

http://www.w3.org/2001/XMLSchema#string

P2860

A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial.

Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26

Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment

SGLT-2 receptor inhibitors for treating patients with type 2 diabetes mellitus: a systematic review and network meta-analysis

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

Dysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional study

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Diabetes treatment in patients with renal disease: Is the landscape clear enough?

The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose.

P304

470-480

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CPT.731

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Kostas Stylianou

P577

2017-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28480956

http://www.w3.org/2001/XMLSchema#string

Renal Effects of SGLT-2 Inhibitors and Other Anti-diabetic Drugs: Clinical Relevance and Potential Risks.

about

P2860

P2860

Renal Effects of SGLT-2 Inhibitors and Other Anti-diabetic Drugs: Clinical Relevance and Potential Risks.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698